Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI

Launched by CASE COMPREHENSIVE CANCER CENTER · Jun 18, 2025

Keywords

ClinConnect Summary

This clinical trial is studying whether an artificial intelligence tool called ChatGPT can help patients better understand their prostate cancer diagnosis and pathology results. Pathology results come from tests done on tissue samples, such as from a prostate biopsy, and can sometimes be hard to understand. The goal is to see if using this AI chatbot makes it easier for patients to learn about their condition in a clear and helpful way.

To be part of this study, you must be 18 years or older, have had a prostate biopsy at the Cleveland Clinic main campus within the last 30 days, and not yet received an explanation of your biopsy results. You also need to speak English and be willing to come in person for a follow-up visit where you will review your results. If you qualify and decide to join, you’ll have the chance to use ChatGPT to help explain your pathology report, and this visit will give you a better understanding of your diagnosis. This study has not started recruiting participants yet, so if you’re interested, you can keep an eye out for when it opens.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants must be \>18 years or age
• • Participants must have received a prostate biopsy at Cleveland Clinic main campus within the last 30 days, and have not received follow-up on their pathology results
• • Participants must be willing to attend an in-person follow-up to review their pathology
• • Participants must be English speaking
• • Participants must provide informed consent
• Exclusion Criteria:
• • • Participants who do not meet the inclusion criteria, as stated above